BACKGROUND: The apolipoprotein E (APOE) ɛ4 allele is associated with episodic memory and spatial navigation deficits. The brain-derived neurotrophic factor (BDNF) Met allele may further worsen memory impairment in APOEɛ4 carriers but its role in APOEɛ4-related spatial navigation deficits has not been established. OBJECTIVE: We examined influence of APOE and BDNF Val66Met polymorphism combination on spatial navigation and volumes of selected navigation-related brain regions in cognitively unimpaired (CU) older adults and those with amnestic mild cognitive impairment (aMCI). METHODS: 187 participants (aMCI [n = 116] and CU [n = 71]) from the Czech Brain Aging Study were stratified based on APOE and BDNF Val66Met polymorphisms into four groups: ɛ4-/BDNFVal/Val, ɛ4-/BDNFMet, ɛ4+/BDNFVal/Val, and ɛ4+/BDNFMet. The participants underwent comprehensive neuropsychological examination, brain MRI, and spatial navigation testing of egocentric, allocentric, and allocentric delayed navigation in a real-space human analogue of the Morris water maze. RESULTS: Among the aMCI participants, the ɛ4+/BDNFMet group had the least accurate egocentric navigation performance (p < 0.05) and lower verbal memory performance than the ɛ4-/BDNFVal/Val group (p = 0.007). The ɛ4+/BDNFMet group had smaller hippocampal and entorhinal cortical volumes than the ɛ4-/BDNFVal/Val (p≤0.019) and ɛ4-/BDNFMet (p≤0.020) groups. Among the CU participants, the ɛ4+/BDNFMet group had less accurate allocentric and allocentric delayed navigation performance than the ɛ4-/BDNFVal/Val group (p < 0.05). CONCLUSION: The combination of APOEɛ4 and BDNF Met polymorphisms is associated with more pronounced egocentric navigation impairment and atrophy of the medial temporal lobe regions in individuals with aMCI and less accurate allocentric navigation in CU older adults.

Department of Clinical Biochemistry Hematology and Immunology Homolka Hospital Prague Czech Republic

International Clinical Research Center St Anne's University Hospital Brno Brno Czech Republic

Memory Clinic Department of Neurology Charles University 2nd Faculty of Medicine and Motol University Hospital Prague Czech Republic

School of Aging Studies University of South Florida Tampa FL USA

See more in PubMed

Maguire EA, Burgess N, Donnett JG, Frackowiak RSJ, Frith CD, O’Keefe J (1998) Knowing where and getting there: A human navigation network. Science 280, 921–924. PubMed

Weniger G, Ruhleder M, Lange C, Wolf S, Irle E (2011) Egocentric and allocentric memory as assessed by virtual reality in individuals with amnestic mild cognitive impairment. Neuropsychologia 49, 518–527. PubMed

Shine JP, Valdés-Herrera JP, Hegarty M, Wolbers T (2016) The human retrosplenial cortex and thalamus code head direction in a global reference frame. J Neurosci 36, 6371–6381. PubMed PMC

Ekstrom AD, Kahana MJ, Caplan JB, Fields TA, Isham EA, Newman EL, Fried I (2003) Cellular networks underlying human spatial navigation. Nature 425, 184–188. PubMed

Coughlan G, Laczó J, Hort J, Minihane A-M, Hornberger M (2018) Spatial navigation deficits — overlooked cognitive marker for preclinical Alzheimer disease? Nat Rev Neurol 14, 496–506. PubMed

Vlček K, Laczó J (2014) Neural correlates of spatial navigation changes in mild cognitive impairment and Alzheimer’s disease. Front Behav Neurosci 8, 89. PubMed PMC

Allison S, Babulal GM, Stout SH, Barco PP, Carr DB, Fagan AM, Morris JC, Roe CM, Head D (2018) Alzheimer disease biomarkers and driving in clinically normal older adults: Role of spatial navigation abilities. Alzheimer Dis Assoc Disord 32, 101–106. PubMed PMC

Rusconi ML, Suardi A, Zanetti M, Rozzini L (2015) Spatial navigation in elderly healthy subjects, amnestic and non amnestic MCI patients. J Neurol Sci 359, 430–437. PubMed

Hort J, Laczo J, Vyhnalek M, Bojar M, Bures J, Vlcek K (2007) Spatial navigation deficit in amnestic mild cognitive impairment. Proc Natl Acad Sci U S A 104, 4042–4047. PubMed PMC

Laczó J, Vlček K, Vyhnálek M, Vajnerová O, Ort M, Holmerová I, Tolar M, Andel R, Bojar M, Hort J (2009) Spatial navigation testing discriminates two types of amnestic mild cognitive impairment. Behav Brain Res 202, 252–259. PubMed

Laczó J, Andel R, Vyhnalek M, Vlcek K, Magerova H, Varjassyova A, Nedelska Z, Gazova I, Bojar M, Sheardova K, Hort J (2012) From Morris water maze to computer tests in the prediction of Alzheimer’s disease. Neurodegener Dis 10, 153–157. PubMed

Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256, 183–194. PubMed

Killiany RJ, Gomez-Isla T, Moss M, Kikinis R, Sandor T, Jolesz F, Tanzi R, Jones K, Hyman BT, Albert MS (2000) Use of structural magnetic resonance imaging to predict who will get Alzheimer’s disease. Ann Neurol 47, 430–439. PubMed

Kogure D, Matsuda H, Ohnishi T, Asada T, Uno M, Kunihiro T, Nakano S, Takasaki M (2000) Longitudinal evaluation of early Alzheimer’s disease using brain perfusion SPECT. J Nucl Med 41, 1155–1162. PubMed

Mokrisova I, Laczo J, Andel R, Gazova I, Vyhnalek M, Nedelska Z, Levcik D, Cerman J, Vlcek K, Hort J (2016) Real-space path integration is impaired in Alzheimer’s disease and mild cognitive impairment. Behav Brain Res 307, 150–158. PubMed

Laczó J, Andel R, Nedelska Z, Vyhnalek M, Vlcek K, Crutch S, Harrison J, Hort J (2017) Exploring the contribution of spatial navigation to cognitive functioning in older adults. Neurobiol Aging 51, 67–70. PubMed

Saunders A, Hulette C, Welsh-Bohmer K, Schmechel D, Crain B, Burke J, Alberts M, Strittmatter W, Breitner J, Rosenberg C, Scott S, Gaskell P, Pericak-Vance M, Roses A (1996) Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer’s disease. Lancet 348, 90–93. PubMed

Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261, 921–923. PubMed

Lim YY, Mormino EC, Alzheimer’s Disease Neuroimaging Initiative (2017) APOE genotype and early β-amyloid accumulation in older adults without dementia. Neurology 89, 1028–1034. PubMed PMC

Mattson MP, Moehl K, Ghena N, Schmaedick M, Cheng A (2018) Intermittent metabolic switching, neuroplasticity and brain health. Nat Rev Neurosci 19, 81–94. PubMed PMC

Li B, Shi J, Gutman BA, Baxter LC, Thompson PM, Caselli RJ, Wang Y, Alzheimer’s Disease Neuroimaging Initiative (2016) Influence of APOE genotype on hippocampal atrophy over time - an N=1925 surface-based ADNI study. PLoS One 11, e0152901. PubMed PMC

Small GW, Ercoli LM, Silverman DH, Huang SC, Komo S, Bookheimer SY, Lavretsky H, Miller K, Siddarth P, Rasgon NL, Mazziotta JC, Saxena S, Wu HM, Mega MS, Cummings JL, Saunders AM, Pericak-Vance MA, Roses AD, Barrio JR, Phelps ME (2000) Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer’s disease. Proc Natl Acad Sci U S A 97, 6037–6042. PubMed PMC

Caselli RJ, Dueck AC, Osborne D, Sabbagh MN, Connor DJ, Ahern GL, Baxter LC, Rapcsak SZ, Shi J, Woodruff BK, Locke DEC, Snyder CH, Alexander GE, Rademakers R, Reiman EM (2009) Longitudinal modeling of age-related memory decline and the APOE ɛ4 effect. N Engl J Med 361, 255–263. PubMed PMC

Xu W-L, Caracciolo B, Wang H-X, Santoni G, Winblad B, Fratiglioni L (2013) Accelerated progression from mild cognitive impairment to dementia among APOE ɛ4ɛ4 carriers. J Alzheimers Dis 33, 507–515. PubMed

Gomar JJ, Conejero-Goldberg C, Huey ED, Davies P, Goldberg TE (2016) Lack of neural compensatory mechanisms of BDNF val66met met carriers and APOE E4 carriers in healthy aging, mild cognitive impairment, and Alzheimer’s disease. Neurobiol Aging 39, 165–173. PubMed PMC

Berteau-Pavy F, Park B, Raber J (2007) Effects of sex and APOE ɛ4 on object recognition and spatial navigation in the elderly. Neuroscience 147, 6–17. PubMed

Laczó J, Andel R, Vyhnalek M, Vlcek K, Magerova H, Varjassyova A, Tolar M, Hort J (2010) Human analogue of the morris water maze for testing subjects at risk of Alzheimer’s disease. Neurodegener Dis 7, 148–152. PubMed

Laczó J, Andel R, Vlček K, Macoška V, Vyhnálek M, Tolar M, Bojar M, Hort J (2011) Spatial navigation and APOE in amnestic mild cognitive impairment. Neurodegener Dis 8, 169–177. PubMed

Laczó J, Andel R, Vyhnalek M, Vlcek K, Nedelska Z, Matoska V, Gazova I, Mokrisova I, Sheardova K, Hort J (2014) APOE and spatial navigation in amnestic MCI: Results from a computer-based test. Neuropsychology 28, 676–684. PubMed

Roses AD, Lutz MW, Amrine-Madsen H, Saunders AM, Crenshaw DG, Sundseth SS, Huentelman MJ, Welsh-Bohmer KA, Reiman EM (2010) A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer’s disease. Pharmacogenomics J 10, 375–384. PubMed PMC

Hayden KM, McEvoy JM, Linnertz C, Attix D, Kuchibhatla M, Saunders AM, Lutz MW, Welsh-Bohmer KA, Roses AD, Chiba-Falek O (2012) A homopolymer polymorphism in the TOMM40 gene contributes to cognitive performance in aging. Alzheimers Dement 8, 381–388. PubMed PMC

Johnson SC, La Rue A, Hermann BP, Xu G, Koscik RL, Jonaitis EM, Bendlin BB, Hogan KJ, Roses AD, Saunders AM, Lutz MW, Asthana S, Green RC, Sager MA (2011) The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ɛ3/ɛ3 genotype. Alzheimers Dement 7, 456–465. PubMed PMC

Laczó J, Andel R, Vyhnalek M, Matoska V, Kaplan V, Nedelska Z, Lerch O, Gazova I, Moffat SD, Hort J (2015) The effect of TOMM40 on spatial navigation in amnestic mild cognitive impairment. Neurobiol Aging 36, 2024–2033. PubMed

Corneveaux JJ, Liang WS, Reiman EM, Webster JA, Myers AJ, Zismann VL, Joshipura KD, Pearson J V., Hu-Lince D, Craig DW, Coon KD, Dunckley T, Bandy D, Lee W, Chen K, Beach TG, Mastroeni D, Grover A, Ravid R, Sando SB, Aasly JO, Heun R, Jessen F, Kölsch H, Rogers J, Hutton ML, Melquist S, Petersen RC, Alexander GE, Caselli RJ, Papassotiropoulos A, Stephan DA, Huentelman MJ (2010) Evidence for an association between KIBRA and late-onset Alzheimer’s disease. Neurobiol Aging 31, 901–909. PubMed PMC

Milnik A, Heck A, Vogler C, Heinze H-J, de Quervain DJ-F, Papassotiropoulos A (2012) Association of KIBRA with episodic and working memory: A meta-analysis. Am J Med Genet B Neuropsychiatr Genet 159B, 958–969. PubMed

Schuck NW, Doeller CF, Schjeide B-MM, Schröder J, Frensch PA, Bertram L, Li S-C (2013) Aging and KIBRA/WWC1 genotype affect spatial memory processes in a virtual navigation task. Hippocampus 23, 919–930. PubMed

Budni J, Bellettini-Santos T, Mina F, Garcez ML, Zugno AI (2015) The involvement of BDNF, NGF and GDNF in aging and Alzheimer’s disease. Aging Dis 6, 331–341. PubMed PMC

Kambeitz JP, Bhattacharyya S, Kambeitz-Ilankovic LM, Valli I, Collier DA, McGuire P (2012) Effect of BDNF val66met polymorphism on declarative memory and its neural substrate: A meta-analysis. Neurosci Biobehav Rev 36, 2165–2177. PubMed

Brown DT, Vickers JC, Stuart KE, Cechova K, Ward DD (2020) The BDNF Val66Met polymorphism modulates resilience of neurological functioning to brain ageing and dementia: A narrative review. Brain Sci 10, 195. PubMed PMC

Deinhardt K, Chao MV (2014) Shaping neurons: Long and short range effects of mature and proBDNF signalling upon neuronal structure. Neuropharmacology 76, 603–609. PubMed PMC

Moya-Alvarado G, Gonzalez A, Stuardo N, Bronfman FC (2018) Brain-derived neurotrophic factor (BDNF) regulates Rab5-positive early endosomes in hippocampal neurons to induce dendritic branching. Front Cell Neurosci 12, 493. PubMed PMC

Panja D, Bramham CR (2014) BDNF mechanisms in late LTP formation: A synthesis and breakdown. Neuropharmacology 76, 664–676. PubMed

Moser M-B, Rowland DC, Moser EI (2015) Place cells, grid cells, and memory. Cold Spring Harb Perspect Biol 7, a021808. PubMed PMC

Narisawa-Saito M, Wakabayashi K, Tsuji S, Takahashi H, Nawa H (1996) Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer’s disease. Neuroreport 7, 2925–2928. PubMed

Hock C, Heese K, Hulette C, Rosenberg C, Otten U (2000) Region-specific neurotrophin imbalances in Alzheimer disease. Arch Neurol 57, 846–851. PubMed

Price JL, Ko AI, Wade MJ, Tsou SK, McKeel DW, Morris JC (2001) Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. Arch Neurol 58, 1395–1402. PubMed

Ozan E, Okur H, Eker Ç, Eker ÖD, Gönül AS, Akarsu N (2010) The effect of depression, BDNF gene val66met polymorphism and gender on serum BDNF levels. Brain Res Bull 81, 61–65. PubMed

Voineskos AN, Lerch JP, Felsky D, Shaikh S, Rajji TK, Miranda D, Lobaugh NJ, Mulsant BH, Pollock BG, Kennedy JL (2011) The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease. Arch Gen Psychiatry 68, 198–206. PubMed

Yang X, Liu P, Sun J, Wang G, Zeng F, Yuan K, Liu J, Dong M, von Deneen KM, Qin W, Tian J (2012) Impact of brain-derived neurotrophic factor Val66Met polymorphism on cortical thickness and voxel-based morphometry in healthy Chinese young adults. PLoS One 7, e37777. PubMed PMC

Pezawas L, Verchinski BA, Mattay VS, Callicott JH, Kolachana BS, Straub RE, Egan MF, Meyer-Lindenberg A, Weinberger DR (2004) The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 24, 10099–10102. PubMed PMC

Hariri AR, Goldberg TE, Mattay VS, Kolachana BS, Callicott JH, Egan MF, Weinberger DR (2003) Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 23, 6690–6694. PubMed PMC

Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112, 257–269. PubMed

Banner H, Bhat V, Etchamendy N, Joober R, Bohbot VD (2011) The brain-derived neurotrophic factor Val66Met polymorphism is associated with reduced functional magnetic resonance imaging activity in the hippocampus and increased use of caudate nucleus-dependent strategies in a human virtual navigation task. Eur J Neurosci 33, 968–977. PubMed PMC

Lim YY, Villemagne VL, Laws SM, Ames D, Pietrzak RH, Ellis KA, Harrington KD, Bourgeat P, Salvado O, Darby D, Snyder PJ, Bush AI, Martins RN, Masters CL, Rowe CC, Nathan PJ, Maruff P (2013) BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer’s disease. Neurobiol Aging 34, 2457–2464. PubMed

Lim YY, Villemagne VL, Laws SM, Ames D, Pietrzak RH, Ellis KA, Harrington K, Bourgeat P, Bush AI, Martins RN, Masters CL, Rowe CC, Maruff P, Lim YY, Villemagne VL, Laws SM, Ames D, Pietrzak RH, Ellis KA, Harrington K (2014) Effect of BDNF Val66Met on memory decline and hippocampal atrophy in prodromal Alzheimer’s disease: A preliminary study. PLoS One 9, e86498. PubMed PMC

Ward D, Summers MJ, Saunders NL, Janssen P, Stuart KE, Vickers JC (2014) APOE and BDNF Val66Met polymorphisms combine to influence episodic memory function in older adults. Behav Brain Res 271, 309–315. PubMed

Lim YY, Villemagne VL, Laws SM, Pietrzak RH, Snyder PJ, Ames D, Ellis KA, Harrington K, Rembach A, Martins RN, Rowe CC, Masters CL, Maruff P (2015) APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer’s disease. Mol Psychiatry 20, 1322–1328. PubMed PMC

Cechova K, Andel R, Angelucci F, Chmatalova Z, Markova H, Laczó J, Vyhnalek M, Matoska V, Kaplan V, Nedelska Z, Ward DD, Hort J (2020) Impact of APOE and BDNF Val66Met gene polymorphisms on cognitive functions in patients with amnestic mild cognitive impairment. J Alzheimers Dis 73, 247–257. PubMed

Sheardova K, Vyhnalek M, Nedelska Z, Laczo J, Andel R, Marciniak R, Cerman J, Lerch O, Hort J (2019) Czech Brain Aging Study (CBAS): Prospective multicentre cohort study on risk and protective factors for dementia in the Czech Republic. BMJ Open 9, e030379. PubMed PMC

Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7, 270–279. PubMed PMC

Yesavage JA (1988) Geriatric Depression Scale. Psychopharmacol Bull 24, 709–711. PubMed

Fazekas F, Chawluk J, Alavi A, Hurtig H, Zimmerman R (1987) MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. Am J Roentgenol 149, 351–356. PubMed

Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31, 545–548. PubMed

Fischl B, van der Kouwe A, Destrieux C, Halgren E, Ségonne F, Salat DH, Busa E, Seidman LJ, Goldstein J, Kennedy D, Caviness V, Makris N, Rosen B, Dale AM (2004) Automatically parcellating the human cerebral cortex. Cereb Cortex 14, 11–22. PubMed

Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van der Kouwe A, Killiany R, Kennedy D, Klaveness S, Montillo A, Makris N, Rosen B, Dale AM (2002) Whole brain segmentation: Automated labeling of neuroanatomical structures in the human brain. Neuron 33, 341–355. PubMed

Desikan RS, Ségonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Buckner RL, Dale AM, Maguire RP, Hyman BT, Albert MS, Killiany RJ (2006) An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31, 968–980. PubMed

Ohnishi T, Matsuda H, Hirakata M, Ugawa Y (2006) Navigation ability dependent neural activation in the human brain: An fMRI study. Neurosci Res 55, 361–369. PubMed

Mosconi L, Brys M, Switalski R, Mistur R, Glodzik L, Pirraglia E, Tsui W, De Santi S, de Leon MJ (2007) Maternal family history of Alzheimer’s disease predisposes to reduced brain glucose metabolism. Proc Natl Acad Sci U S A 104, 19067–19072. PubMed PMC

Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D (1996) Preclinical evidence of Alzheimer’s disease in persons homozygous for the ɛ4 allele for apolipoprotein E. N Engl J Med 334, 752–758. PubMed

Nedelska Z, Andel R, Laczó J, Vlcek K, Horinek D, Lisy J, Sheardova K, Bures J, Hort J (2012) Spatial navigation impairment is proportional to right hippocampal volume. Proc Natl Acad Sci U S A 109, 2590–2594. PubMed PMC

Jack CR, Petersen RC, O’Brien PC, Tangalos EG (1992) MR-based hippocampal volumetry in the diagnosis of Alzheimer’s disease. Neurology 42, 183–188. PubMed

Singer JD, Willett JB (2009), Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence, Oxford University Press.

Tabachnick BG, Fidell LS (2007) Using Multivariate Statistics, Allyn & Bacon, Boston, MA.

Koelewijn L, Lancaster TM, Linden D, Dima DC, Routley BC, Magazzini L, Barawi K, Brindley L, Adams R, Tansey KE, Bompas A, Tales A, Bayer A, Singh K (2019) Oscillatory hyperactivity and hyperconnectivity in young APOE-ɛ4 carriers and hypoconnectivity in Alzheimer’s disease. Elife 8, e36011. PubMed PMC

Chen Y, Liu Z, Zhang J, Chen K, Yao L, Li X, Gong G, Wang J, Zhang Z (2017) Precuneus degeneration in nondemented elderly individuals with APOE ɛ4: Evidence from structural and functional MRI analyses. Hum Brain Mapp 38, 271–282. PubMed PMC

Angelucci F, Gelfo F, De Bartolo P, Caltagirone C, Petrosini L (2011) BDNF concentrations are decreased in serum and parietal cortex in immunotoxin 192 IgG-Saporin rat model of cholinergic degeneration. Neurochem Int 59, 1–4. PubMed

Gazova I, Laczó J, Rubinova E, Mokrisova I, Hyncicova E, Andel R, Vyhnalek M, Sheardova K, Coulson EJ, Hort J (2013) Spatial navigation in young versus older adults. Front Aging Neurosci 5, 94. PubMed PMC

Rodgers MK, Sindone JA, Moffat SD (2012) Effects of age on navigation strategy. Neurobiol Aging 33, 202.e15–202.e22. PubMed PMC

Allison SL, Fagan AM, Morris JC, Head D (2016) Spatial navigation in preclinical Alzheimer’s disease. J Alzheimers Dis 52, 77–90. PubMed PMC

Tu S, Spiers HJ, Hodges JR, Piguet O, Hornberger M (2017) Egocentric versus allocentric spatial memory in behavioral variant frontotemporal dementia and Alzheimer’s disease. J Alzheimers Dis 59, 883–892. PubMed

Mattsson N, Groot C, Jansen WJ, Landau SM, Villemagne VL, Engelborghs S, Mintun MM, Lleo A, Molinuevo JL, Jagust WJ, Frisoni GB, Ivanoiu A, Chételat G, Resende de Oliveira C, Rodrigue KM, Kornhuber J, Wallin A, Klimkowicz-Mrowiec A, Kandimalla R, Popp J, Aalten PP, Aarsland D, Alcolea D, Almdahl IS, Baldeiras I, van Buchem MA, Cavedo E, Chen K, Cohen AD, Förster S, Fortea J, Frederiksen KS, Freund-Levi Y, Gill KD, Gkatzima O, Grimmer T, Hampel H, Herukka S-K, Johannsen P, van Laere K, de Leon MJ, Maier W, Marcusson J, Meulenbroek O, Møllergård HM, Morris JC, Mroczko B, Nordlund A, Prabhakar S, Peters O, Rami L, Rodríguez-Rodríguez E, Roe CM, Rüther E, Santana I, Schröder J, Seo SW, Soininen H, Spiru L, Stomrud E, Struyfs H, Teunissen CE, Verhey FRJ, Vos SJB, van Waalwijk van Doorn LJC, Waldemar G, Wallin ÅK, Wiltfang J, Vandenberghe R, Brooks DJ, Fladby T, Rowe CC, Drzezga A, Verbeek MM, Sarazin M, Wolk DA, Fleisher AS, Klunk WE, Na DL, Sánchez-Juan P, Lee DY, Nordberg A, Tsolaki M, Camus V, Rinne JO, Fagan AM, Zetterberg H, Blennow K, Rabinovici GD, Hansson O, van Berckel BNM, van der Flier WM, Scheltens P, Visser PJ, Ossenkoppele R (2018) Prevalence of the apolipoprotein E ɛ4 allele in amyloid β positive subjects across the spectrum of Alzheimer’s disease. Alzheimers Dement 14, 913–924. PubMed

Franzmeier N, Ren J, Damm A, Monté-Rubio G, Boada M, Ruiz A, Ramirez A, Jessen F, Düzel E, Rodríguez Gómez O, Benzinger T, Goate A, Karch CM, Fagan AM, McDade E, Buerger K, Levin J, Duering M, Dichgans M, Suárez-Calvet M, Haass C, Gordon BA, Lim YY, Masters CL, Janowitz D, Catak C, Wolfsgruber S, Wagner M, Milz E, Moreno-Grau S, Teipel S, Grothe MJ, Kilimann I, Rossor M, Fox N, Laske C, Chhatwal J, Falkai P, Perneczky R, Lee J-H, Spottke A, Boecker H, Brosseron F, Fliessbach K, Heneka MT, Nestor P, Peters O, Fuentes M, Menne F, Priller J, Spruth EJ, Franke C, Schneider A, Westerteicher C, Speck O, Wiltfang J, Bartels C, Araque Caballero MÁ, Metzger C, Bittner D, Salloway S, Danek A, Hassenstab J, Yakushev I, Schofield PR, Morris JC, Bateman RJ, Ewers M (2019) The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer’s disease. Mol Psychiatry, doi: 10.1038/s41380-019-0404-6 PubMed DOI PMC

Boots EA, Schultz SA, Clark LR, Racine AM, Darst BF, Koscik RL, Carlsson CM, Gallagher CL, Hogan KJ, Bendlin BB, Asthana S, Sager MA, Hermann BP, Christian BT, Dubal DB, Engelman CD, Johnson SC, Okonkwo OC (2017) BDNF Val66Met predicts cognitive decline in the Wisconsin Registry for Alzheimer’s Prevention. Neurology 88, 2098–2106. PubMed PMC

Petersen RC, Smith GE, Ivnik RJ, Tangalos EG, Schaid DJ, Thibodeau SN, Kokmen E, Waring SC, Kurland LT (1995) Apolipoprotein E status as a predictor of the development of Alzheimer’s disease in memory-impaired individuals. JAMA 273, 1274–1278. PubMed

Bunce D, Anstey KJ, Cherbuin N, Gautam P, Sachdev P, Easteal S (2012) APOE genotype and entorhinal cortex volume in non-demented community-dwelling adults in midlife and early old age. J Alzheimers Dis 30, 935–942. PubMed

Hsiao Y-H, Hung H-C, Chen S-H, Gean P-W (2014) Social interaction rescues memory deficit in an animal model of Alzheimer’s disease by increasing BDNF-dependent hippocampal neurogenesis. J Neurosci 34, 16207–16219. PubMed PMC

Parizkova M, Lerch O, Moffat SD, Andel R, Mazancova AF, Nedelska Z, Vyhnalek M, Hort J, Laczó J (2018) The effect of Alzheimer’s disease on spatial navigation strategies. Neurobiol Aging 64, 107–115. PubMed

Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D, Saunders AM, Hardy J (2005) From The Cover: Correlations between apolipoprotein E 4 gene dose and brain-imaging measurements of regional hypometabolism. Proc Natl Acad Sci U S A 102, 8299–8302. PubMed PMC

Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82, 239–259. PubMed

Chetelat G, Desgranges B, de la Sayette V, Viader F, Berkouk K, Landeau B, Lalevée C, Le Doze F, Dupuy B, Hannequin D, Baron J-C, Eustache F (2003) Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment. Brain 126, 1955–1967. PubMed

Cerman J, Andel R, Laczo J, Vyhnalek M, Nedelska Z, Mokrisova I, Sheardova K, Hort J (2018) Subjective spatial navigation complaints - A frequent symptom reported by patients with subjective cognitive decline, mild cognitive impairment and Alzheimer’s disease. Curr Alzheimer Res 15, 219–228. PubMed

Spatial navigation deficits in early Alzheimer's disease: the role of biomarkers and APOE genotype

Mild behavioral impairment in early Alzheimer's disease and its association with APOE and BDNF risk genetic polymorphisms

Six genetically linked mutations in the CD36 gene significantly delay the onset of Alzheimer's disease